Quest PharmaTech (TSXV:QPT) EV-to-EBIT : -0.19 (As of May. 22, 2024)

Quest PharmaTech EV-to-EBIT Chart

Quest PharmaTech Annual Data
	Trend	Jan14	Jan15	Jan16	Jan17	Jan18	Jan19	Jan20	Jan21	Jan22	Jan23
EV-to-EBIT		Get a 7-Day Free Trial					-3.39	-1.39	0.17	-0.18	-1.70

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
EV-to-EBIT	Get a 7-Day Free Trial															-0.20	-1.70	-1.17	-0.66	-0.54

Competitive Comparison of Quest PharmaTech's EV-to-EBIT

For the Biotechnology subindustry, Quest PharmaTech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest PharmaTech's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's EV-to-EBIT falls into.

Quest PharmaTech EV-to-EBIT Calculation

Quest PharmaTech's EV-to-EBIT for today is calculated as:

Quest PharmaTech's current Enterprise Value is C$4.29 Mil.
Quest PharmaTech's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-22.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech  (TSXV:QPT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Quest PharmaTech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 is calculated as:

Quest PharmaTech's Enterprise Value for the quarter that ended in Oct. 2023 was C$11.90 Mil.
Quest PharmaTech's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-22.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description